Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment
BABYCRY_1000
2 other identifiers
observational
1,100
1 country
1
Brief Summary
Crying is a vital communication signal for the baby. Product of a complex physiological process, it reflects not only the organization and functioning of the cortical central nervous system and the function of sympathetic and parasympathetic autonomic regulation but also the integrity of three entities: the lungs responsible for ventilatory mechanics and respiratory rhythm, the larynx and its vocal cords as a phonatory organ, and the oropharyngeal tract guaranteeing the resonance of the sound emitted by the vocal cords. Crying is usually caused by pain, discomfort, hunger, or separation from parents or other caregivers. Crying carries essential information from birth, the expression of which depends closely on the neuroanatomical and functional brain integrity of the child. On a bioacoustic level, crying consists of sequences of complex acoustic signals produced by the vocal folds and filtered by the vocal tract. The vibration frequency of the vocal cords determines the cry's fundamental frequency f0 (and the harmonic frequencies), which is responsible for its more or less low or high pitch. Other acoustic cues also characterize each baby's cry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2024
CompletedStudy Start
First participant enrolled
March 20, 2024
CompletedFirst Posted
Study publicly available on registry
March 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
May 28, 2025
May 1, 2025
4 years
March 20, 2024
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fundamental frequency f0 (Hz)
Fundamental frequency f0 (Hz) defined from a crying sequence, the most characteristic elementary index of their individual bioacoustic signature.
At inclusion
Bailey-4 quantitative scale
neurodevelopment at age 2 measured by the Bailey-4 quantitative scale. The final score is from 40 (Very weak neurodevelopment) to 160 (Very good neurodevelopment)
At 2 years
Secondary Outcomes (7)
Percentage voiced frames
At inclusion
Harmonics of f0 (Hz)
At inclusion
Median pitch f0 (Hz)
At inclusion
Harmonicity (dB)
At inclusion
Jitter (Percentage),
At inclusion
- +2 more secondary outcomes
Study Arms (2)
birth of term babies
Study of crying in a group of newborns (birth of term babies)
Premature babies
Study of crying in a group of newborns (Premature babies )
Interventions
Evaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.
Eligibility Criteria
Full-term baby \> 37 weeks Premature baby \< 37 weeks
You may qualify if:
- For a full-term baby \> 37 weeks
- For a premature baby \< 37 weeks
- Born in the maternity ward of the Saint-Etienne University Hospital
- Holder of parental authority having received informed information about the study and their right to object
- Holder of parental authority affiliated to or beneficiary of a social security system
- Eutrophic between the 10th and 90th percentile on the neonatal curves)
You may not qualify if:
- Refusal of participation by the holder of parental authority
- Antenatal pathology, nor perinatal asphyxia
- Holder of minor parental authority
- Holder of parental authority under curatorship or guardianship
- Abnormal T1 audiological screening test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
HUGUES PATURAL, MD-PhD
CHU DE SAINT-ETIENNE
- STUDY CHAIR
Nicolas MATHEVON, PhD
Saint-Etienne University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2024
First Posted
March 27, 2024
Study Start
March 20, 2024
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share